Euro-Australian research infrastructure collaboration in the molecular life sciences

to
AEST

308 Queen Street
Brisbane
UQ Brisbane City QLD 4000
Australia

An insight into the partnership between the Australian BioCommons and ELIXIR

Delivery format: Hybrid

Positive relationships with infrastructure and informatics providers at local and global scales have yielded successful outcomes in the life science research infrastructure community. The relationship betweenELIXIR and Australian BioCommons – a digital infrastructure enhancing Australia’s research capabilities across environmental, agricultural and biomedical science – exemplifies such successful collaborations.

Over the last five years, both ELIXIR and Australian BioCommons have prioritised partnerships with national informatics and infrastructure providers to the benefit of multiple national molecular life science audiences. Globally, Australian BioCommons and ELIXIR are into their fourth year of an AUS-EU collaboration agreement – a successful global partnership that has yielded fruitful outcomes for the global community of practitioners.

This side event meeting is an opportunity to showcase some examples of project outcomes that have emerged from partnerships and relationships across Europe and Australia, as well as globally. We will focus on the collaboration agreement and provide examples of successes to date, including key outcomes and future plans. We plan to discuss common themes and emergent strategies.

Find out more

  • To find more about ICRI 2024 and this event, visit the ICRI website.
  • If you have registered for the ICRI meeting, in person or online, you can register for this side event through ICRI's Brella App.
Speakers
Kelly Scarlett (Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy (NCRIS))
Nigel Ward (Australian BioCommons)
Fotis Psomopoulos (Centre for Research and Technology Hellas (CERTH); ELIXIR)
Gerry Reilly (BioFAIR)
Partners